‹ Home
Exported

CSTE National ELR Workgroup

Welcome to the CSTE National ELR Workgroup Basecamp! We hope you will utilize the space to share resources with colleagues, start discussion threads, and identify topics for the workgroup to tackle on future calls. All workgroup members will have the opportunity to join. Please note that you may edit your notification preferences to suit your needs (and your email inbox). If you are not already on the ELR distribution list and would like to receive call communications, please enroll using this subscription form (copy and paste in browser): https://app.smartsheet.com/b/form/5a91a4579952496682084796b82112e6
Becky Lampkins, Manager, Surveillance/Informatics Program at CSTEMegan Toe, CSTEScott Troppy, Surveillance Epidemiologist at MA DPHMeredith Lichtenstein, CSTEAmy Drake, NMJohn RobertsNancy Barrett, Epi 4/PH Informatics SpecialistErin Holt, TDHRita Altamore, EpidemiologistDavid DiCesareJason HallWalter Kemper, ELR Coordinator, NC DHHS Div of Public HealthJulie LuepkeCarmen Pugh, Labcorp Manager State Reporting at LabCorpTom Safranek +399 others
Posted by Brooke Beaulieu ·

Additional reporting requirements for pooled specimen for COVID-19

Hi folks,

Trying to get some insight from the public health perspective on the importance and priority of implementing additional reporting requirements for pooled specimen for COVID-19.

Currently results from pooled testing, when performed under CLIA regulation, are reported to providers and PHAs the same way as any other result related to COVID-19 testing, though either a note or a specific code might be used to identify the result as having been tested as part of a pooled sample. Pooled testing as part of surveillance - not under CLIA waiver (e.g., college dorm testing), where the results are not reportable at the individual level, are not part of the current reporting stream – is that something that needs to be considered?

Main questions for your feedback:
  1. What is the priority of getting additional data on test results from a pooled specimen? 
  2. From the public health perspective, why are these data important? Do the data guide decision making at the public health level? 
  3. If these data are useful, what data elements are important and why? Indication that the sample was part of a pool and the size of the pool could be a starting point, but are there other data elements that would be beneficial?
Many thanks for your feedback!

Brooke